Judah Frommer
Stock Analyst at Morgan Stanley
(3.35)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
APLS Apellis Pharmaceutic... | Maintains: Equal-Weight | 25 26 | 23.87 | 8.92% | 2 | Jul 2, 2025 | |
BPMC Blueprint Medicines | Maintains: Equal-Weight | 102 129 | 129.46 | -0.36% | 2 | Jun 5, 2025 | |
CLDX Celldex Therapeutics | Maintains: Overweight | 46 43 | 20.01 | 114.89% | 2 | May 9, 2025 | |
ABVX Abivax | Assumes: Equal-Weight | 12 | 69.02 | -82.61% | 1 | Mar 20, 2025 | |
RGNX Regenxbio | Maintains: Overweight | 22 24 | 7.46 | 221.72% | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 31 22 | 31.5 | -30.16% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 6 | 5.53 | 8.5% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 106 | 69.11 | 53.38% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 9.95 | 251.76% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 1.55 | 738.71% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 3 | 2.25 | 33.33% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 | 2.62 | 1426.72% | 8 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | n/a | n/a | 3 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.41 | 821.99% | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 45.74 | -34.41% | 8 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 23 | 13.14 | 75.04% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 | 43.3 | 15.47% | 9 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 141 | 17.95 | 685.52% | 13 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 156 | 17.16 | 809.09% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 9 | 3.96 | 127.27% | 5 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 138 | n/a | n/a | 6 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 22 | 24.4 | -9.84% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 6.21 | 12.72% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 1 | n/a | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | 6.35 | 25.98% | 5 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 21.27 | 116.27% | 5 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 7 | 1.85 | 278.38% | 6 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 51 55 | 14.13 | 289.24% | 3 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 112.87 | -59.25% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 4 | n/a | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 10 | n/a | n/a | 2 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 97.44 | -49.71% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 328 370 | 989.13 | -62.59% | 2 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 31 | 78.28 | -60.4% | 6 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 76 | 79.86 | -4.83% | 8 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 182 | 114.55 | 58.88% | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 107 | 114.31 | -6.39% | 13 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 95 | 135.07 | -29.67% | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 18 | 19.36 | -7.02% | 1 | Jul 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 93 116 | 131.93 | -12.07% | 12 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 38 | 107.44 | -64.63% | 4 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 22 | 148.72 | -85.21% | 1 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 33 35 | 74.37 | -52.94% | 9 | Apr 29, 2020 |